Jeff Bezos's Blue Origin weighs first external fundraising - FT

Published on 05/13/2026 at 12:16 am EDT

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

Already a customer? Log In

01:02pm	Gavi plans to use U.S. cash for malaria, while meeting Kennedy's conditions	RE
12:59pm	India's RBI offers concessional swaps, allows leverage for NRI deposits to drive forex inflows	RE
12:54pm	Etihad Airways CEO Says Carrier Is Discounting Tickets	MT
12:51pm	EU wheat briefly dips below EUR200 on good supply prospects, recovers later	RE
12:42pm	Egypt signs deals with UAE's AlcaZar Energy for $420 million wind power project in Red Sea	RE
12:38pm	Delta President on Plans for Middle East Investment	MT
12:34pm	W.Africa Crude-Differentials hold steady	RE
12:28pm	US military disables unladen oil tanker headed to Iran	RE
12:25pm	Redemption Angst Spills Into Private Equity	MT
12:25pm	Mexico inflation likely slowed again in May, still above cenbank target	RE
12:18pm	ENERGY WATCH: Mideast flare-up	RE
12:18pm	EU wheat briefly dips below EUR200 on good supply prospects, then recovers	RE
12:18pm	Italy regulator drops investigation into Meta's WhatsApp AI bot	RE
12:14pm	JetBlue CEO on Future Plans and Potential Consolidation	MT
12:08pm	Azeri BTC daily crude oil exports set to decline 3% in July versus June, schedule shows	RE

Convertible bonds on track for a record year

2026 World Cup and the Stock Market: Football's Great Marketplace

What does the ECB have in store for us?

As Apple's WWDC conference kicks off, investors want to know if AI will save Siri

W.Africa Crude-Differentials hold steady

UK's FTSE 100 recovers from lows as Israel and Iran halt strikes on each other

	Chips take a pounding
	Markets Ask AI for Receipts
	Analyst recommendations: Crocs, Broadcom, Fortinet, Humana, Micron…
	Blistering AI rally turns ugly
	Chinese military hovered as global executives flocked to Taiwan tech show
	Rheinmetall anticipates "significant improvement" in business in Q2
	Meta shares weighed on by capital increase rumors
	Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss market
	Futures slide; MPS takes center stage
	Clínica Baviera, the copy-paste machine